Quick Summary
Covering the latest research from top Wall Street investment banks

Short-term earnings under pressure, but emerging brands and shareholder returns support maintaining OW

Institution
J.P. Morgan
Date
2026-04-24
Authors
Qian Yao, Carson Fan
Company
Proya Cosmetics Co., Ltd.
Ticker
603605.SS
Industry
Cosmetics / Consumer Staples
Rating
Overweight
BullishLow confidenceDespite short-term earnings pressure and downward earnings revisions, the report believes emerging brand ramp-up, offline recovery, improved shareholder returns, and a multi-brand portfolio will support the company’s return to growth in 2026.
AuthorsQian Yao, Carson Fan
Target priceRmb130.00
CoverageAsia-Pacific
Business segmentsCore Proya brand、Skincare、Color cosmetics、Hair and body care、Emerging brand portfolio: Off & Relax, Insbaha, Awaken Seeds, Timage, Correctors, Hapsode
Research firm divisions/subsidiariesJ.P. Morgan Securities (China) Company Limited(Other)

AI summary card

Short-term earnings under pressure, but emerging brands and shareholder returns support maintaining OW

J.P. Morgan lowered Proya’s 2026/2027 earnings forecasts and target price, but still favors its hero-product strategy, channel adaptability, multi-brand portfolio, and higher shareholder returns.

Maintain OW; current price Rmb60.76, December 2026 target price Rmb130, implying about 28x 12-month forward P/E.
Maintain OWTarget price Rmb130Emerging brands ramping upImproved shareholder returnsCore brand under pressureDCF valuation
  • 1Q26 revenue and attributable net profit fell 2% and 6% YoY, respectively, but the declines narrowed versus 4Q25 and 3Q25.
  • Sales of the core Proya brand fell 19% YoY in 2H25, mainly due to a high Tmall base and intensified competition.
  • Emerging brands such as Off & Relax, Insbaha, and Awaken Seeds are growing rapidly, with their sales contribution exceeding 10% in 2025.
  • The 2025 payout ratio increased to about 53%, above 30% in 2024, and the company has executed more than Rmb100mn of share buybacks.
  • 2026/2027 earnings forecasts were cut by about 19% to 20%, and the target price was lowered from Rmb154 to Rmb130.

Report interpretation

Overview

The report is J.P. Morgan’s earnings review of Proya Cosmetics Co., Ltd. (603605.SS). In 1Q26, the company’s revenue fell 2% YoY and earnings fell 6% YoY, remaining weak, but the revenue decline narrowed compared with previous quarters. The report believes short-term pressure mainly comes from slowing sales of the core Proya brand, especially due to a high base and intensified competition on the Tmall channel; however, ramp-up of emerging brands, recovery in offline channels, supply chain and formulation optimization that cushion cost pressure, and more proactive dividends and buybacks still support maintaining the OW rating.

Core views

The core view is that short-term earnings forecasts need to be revised down, but the medium- to long-term investment thesis remains intact. J.P. Morgan believes Proya is well positioned to continue gaining market share through its hero-product-driven strategy, its ability to adapt quickly to channel and marketing changes, and its diversified brand portfolio spanning skincare, color cosmetics, and hair and body care. The report forecasts 2025-2028 revenue and earnings CAGR of 9% and 11%, respectively, with operating margin rising from 16.9% in 2025 to 17.9% in 2028E.

Analysis framework

The report analyzes quarterly results, annual financial data, brand and channel performance, shareholder return plans, and a DCF valuation framework. On earnings, it focuses on comparing changes in revenue, margins, expense ratios, and net profit across 1Q26, 4Q25, and FY25; on operations, it focuses on recovery of the core brand, growth of emerging brands, optimization of Tmall and Douyin channels, and offline recovery; on valuation, it uses DCF and references 12-month forward P/E.

Methodology notes

  • Valuation methodsDCF

    Discounted cash flow valuation

    The Rmb130 target price is based on DCF valuation, assuming WACC of 10.6%, a risk-free rate of 4.0%, an equity risk premium of 6.0%, a cost of equity of 12.6%, and a terminal growth rate of 2.5%.

  • Earnings analysisYoY growth and margin breakdown

    Changes in revenue, expense ratios, and margins

    The report uses changes in revenue, gross margin, operating margin, net margin, and selling expense ratio in 1Q26, 4Q25, and FY25 to assess sources of earnings pressure and signs of recovery.

  • Investment thesisBrand portfolio and channel strategy analysis

    Hero products, emerging brands, and channel adaptability

    The report breaks down the company’s growth drivers into recovery of the core Proya brand, ramp-up of emerging brands, optimization of operations on Douyin and Tmall, offline recovery, and overseas expansion, among other factors.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Proya (603605.SS)
    Research target
    Strengths
    A leading domestic cosmetics company with a hero-product-driven strategy, rapid channel adaptability, a diversified brand portfolio, and relatively high shareholder returns.
    Weaknesses
    The core Proya brand is under short-term pressure, the Tmall channel is affected by a high base and intensified competition, and a higher selling expense ratio is suppressing margins.
    Comparison
    The report believes the 1Q26 revenue decline narrowed versus 4Q25 and 3Q25, showing marginal trend improvement; however, performance was still weaker than previous expectations, so earnings forecasts were cut.
    Risks
    Higher-than-expected selling expenses, unsuccessful launches of new star products, weaker-than-expected brand strength improvement, and a weaker-than-expected retail environment.
  • Emerging brand portfolio
    Growth driver
    Strengths
    Brands such as Off & Relax, Insbaha, and Awaken Seeds are growing rapidly, contributing more than 10% of 2025 sales, with some brands doubling or nearly doubling sales in 2025 or 1Q26.
    Weaknesses
    Emerging brands are still in the investment and scaling stage and remain highly dependent on marketing, channel expansion, and the pace of new product launches.
    Comparison
    Compared with the slowdown of the core Proya brand, emerging brands provide a second growth curve at the portfolio level.
    Risks
    Underperformance in brand upgrading, new product launches, or channel breakthroughs could weaken their growth contribution.
  • Tmall and Douyin channels
    Key variables for operational recovery
    Strengths
    Tmall is focused on the 618 campaign, new product launches, and improving operating efficiency; Douyin reaches younger consumers through stronger content, optimization of mid-tier and long-tail KOL and KOC livestreaming, and new product promotion.
    Weaknesses
    The high base on Tmall and intensified competition remain the core sources of pressure.
    Comparison
    Douyin and content e-commerce are viewed as upside catalysts from channel innovation, while Tmall is more of a recovery variable.
    Risks
    Rising platform traffic costs, weaker-than-expected livestream conversion, or lower marketing efficiency.

Key data

  • 1Q26 revenueRmb2,305mn, YoY -2%The decline narrowed compared with 4Q25 revenue YoY of -8%.
  • 1Q26 attributable net profitRmb367mn, YoY -6%Core net profit fell 10% YoY, with a higher selling expense ratio dragging on earnings.
  • FY25 revenueRmb10,597mn, YoY -2%FY25 attributable net profit was Rmb1,498mn, down 3% YoY.
  • 2026/2027 earnings forecast revisionRevised EPS lowered from Rmb5.09/Rmb5.72 to Rmb4.09/Rmb4.65, respectivelyThe cuts of 19.6% and 18.7%, respectively, reflect intensified competition and long-term investment.
  • Target priceRmb130, previous Rmb154Based on DCF valuation, implying about 28x 12-month forward P/E.
  • Current priceRmb60.76As of the close on April 23, 2026.
  • 2025 payout ratioabout 53%Higher than 30% in 2024; the company also announced an Rmb80-150mn buyback plan and has already executed more than Rmb100mn.
  • 2025 to 2028E growth outlookRevenue CAGR 9%, earnings CAGR 11%Operating margin is expected to improve from 16.9% to 17.9%.
  • 2024 market share4.0%The company is one of the leading domestic brands in China’s mass beauty market.

Impact & implications

The investment implication conveyed by the report is that the market needs to digest short-term pressure on the core brand and main online channels, but if emerging brands, Douyin content and livestream optimization, offline recovery, and the hero-product strategy deliver, the company may still re-enter a steady growth trajectory. The target price cut indicates a slower pace of earnings recovery, but maintaining OW shows the analyst believes the current valuation already fairly reflects short-term pressure.

Risks

  • Selling expenses are higher than expected, leading to weaker profitability.
  • New star products or the hero-product strategy fail to deliver successfully.
  • Brand strength improvement falls short of expectations.
  • The overall retail environment is weaker than expected.
  • Recovery of the core Proya brand is slower than expected, especially if competitive pressure on the Tmall channel persists.
  • Scaling emerging brands requires continued investment, and if expense efficiency declines it may drag on margins.

What to watch

  • Progress toward the 2026 equity incentive targets of 5% YoY growth in revenue and earnings.
  • Recovery performance of the core Proya brand during Tmall 618 and subsequent major promotions.
  • Conversion efficiency of Douyin content marketing, mid-tier and long-tail KOL/KOC livestreaming, and new product promotion.
  • Sales growth and profit contribution of emerging brands such as Off & Relax, Insbaha, Awaken Seeds, Timage, and Correctors.
  • Whether offline channels can sustain the 29% YoY recovery trend seen in 1Q26.
  • Dividend payout ratio, execution progress of share buybacks, and sustainability of shareholder returns.
  • Whether the selling expense ratio declines and whether gross margin improvement can offset pressure from marketing investment.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins